The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

BACKGROUND: Obesity, type 2 diabetes mellitus (T2D) and unhealthy blood lipid profile are strongly associated with the risk of developing cardiovascular disease (CVD). We examined whether blood lipid changes with short term administration of the weight lowering drug, sibutramine and lifestyle modifi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Weeke, Peter, Andersson, Charlotte, Fosbøl, Emil L, Brendorp, Bente, Køber, Lars, Sharma, Arya M, Finer, Nick, James, Philip T, Caterson, Ian D, Rode, Richard A, Torp-Pedersen, Christian
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2010
Matèries:
Research article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2848038/
https://ncbi.nlm.nih.gov/pubmed/20184783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6823-10-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars